Synergistic effects of ketamine and azole derivatives on Candida spp. resistance to fluconazole

Future Microbiol. 2020 Feb:15:177-188. doi: 10.2217/fmb-2019-0082. Epub 2020 Feb 20.

Abstract

The emergence of Candida spp. with resistance to antifungal molecules, mainly the azole class, is an increasing complication in hospitals around the globe. Aim: In the present research, we evaluated the synergistic effects of ketamine with two azole derivatives, itraconazole and fluconazole, on strains of Candida spp. to fluconazole. Materials & methods: The drug synergy was evaluated by quantifying the fractional inhibitory concentration index and by fluorescence microscopy and flow cytometry techniques. Results: Our achievements showed a synergistic effect between ketamine in addition to the two antifungal agents (fluconazole and itraconazole) against planktonic cells and biofilms of Candida spp. Conclusion: This combination promoted alteration of membrane integrity, generation of reactive oxygen species, damage to and DNA and externalization of phosphatidylserine.

Keywords: Candida spp.; ROS; apoptosis; biofilm; fluconazole resistance; ketamine.

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Biofilms / drug effects
  • Candida / drug effects*
  • Candida / physiology
  • Candida albicans / drug effects
  • Candida albicans / physiology
  • Cell Survival / drug effects
  • DNA Damage
  • DNA Fragmentation
  • DNA, Fungal / drug effects
  • Drug Resistance, Fungal
  • Drug Synergism
  • Fluconazole / pharmacology*
  • Itraconazole / pharmacology*
  • Ketamine / pharmacology*
  • L Cells
  • Membrane Potential, Mitochondrial / drug effects
  • Mice
  • Microbial Sensitivity Tests
  • Microbial Viability
  • Phosphatidylserines / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Antifungal Agents
  • DNA, Fungal
  • Phosphatidylserines
  • Reactive Oxygen Species
  • Itraconazole
  • Ketamine
  • Fluconazole